Integrating radiosensitivity index and triple-negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple-negative breast cancer

Xinxin Rao; Xuanyi Wang; Chao He; YiZhou Jiang; ZhiMing Shao; Yan Feng; Jundong Zhou; Xiaomao Guo; Xingxing Chen

doi:10.1002/ctm2.1787

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (8) : e1787 DOI: 10.1002/ctm2.1787

LETTER TO THE JOURNAL

Integrating radiosensitivity index and triple-negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple-negative breast cancer

Xinxin Rao ¹^,²^,³
, Xuanyi Wang ¹^,²^,³
, Chao He ⁴
, YiZhou Jiang ²^,⁵
, ZhiMing Shao ²^,⁵
, Yan Feng ¹^,²^,³
, Jundong Zhou ⁴^,⁶^,^†
, Xiaomao Guo ¹^,²^,³^,^†
, Xingxing Chen ¹^,²^,³^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Xinxin Rao,Xuanyi Wang,Chao He,YiZhou Jiang,ZhiMing Shao,Yan Feng,Jundong Zhou,Xiaomao Guo,Xingxing Chen. Integrating radiosensitivity index and triple-negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple-negative breast cancer. Clinical and Translational Medicine, 2024, 14(8): e1787 DOI:10.1002/ctm2.1787

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.